Miguel Forte

Chief Executive Officer • Bone Therapeutics

Dr. Forte has significant experience in regenerative medicine and in the cell therapy industry, most recently as Chief Executive Officer of Zelluna Immunotherapy, a biopharma company focusing on developing transformative T cell receptors (TCR) based cellular immunotherapies for the treatment of cancers. He is currently also serving as Chief Commercialization Officer and Chair of the Commercialization Committee of the International Society of Cellular Therapy (ISCT).

Also Speaking

Peter Walters

Director, Advanced Therapies • CRB

Dominic Clarke

Chief Technology Officer • Discovery Life Sciences

Shyam Patal

Director of Business Development  • CIRM

Event Info


Fun Run